Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Pharmaceutical Medicine|July 8, 2024
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical TrialsGareth Baynam, Simeón Baker, Charles Steward, et al.
Pharmaceutical Medicine|July 13, 2024
Statistical Signal Detection Algorithm in Safety Data: A Proprietary Method Compared to Industry Standard MethodsEugenia Bastos, Jeff K Allen, Jeff Philip
Pharmaceutical Medicine|July 13, 2024
How Can General Managers Best Leverage Medical Affairs Now and in the Future?Jon Zdon, Greta-James Chatgilaou, David Henderson, et al.
Pharmaceutical Medicine|May 5, 2024
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in NigeriaUchenna Geraldine Elemuwa, Fraden Bitrus, Ibrahim Adekunle Oreagba, et al.
Pharmaceutical Medicine|April 29, 2024
Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA AssessmentsRyosuke Kuribayashi, Aya Hariu, Ayuki Nakano, et al.
Pharmaceutical Medicine|January 20, 2026
Best Practices for Medical Information Global Response Documents from phactMI and MILESusan Wnorowski, Faith Niemoller, Anja Glaetzer, et al.
Pharmaceutical Medicine|January 27, 2026
Shaping the Future of Evidence Generation: Real-World Data to Drive Healthcare Transformation and Patient-Centered DecisionsJesús Medina, Joaquín Sánchez-Covisa, Javier Nuevo, et al.
Pharmaceutical Medicine|December 16, 2025
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting PracticesBarbara A Hendrickson, Cynthia McShea, Tarek A Hammad, et al.
Pharmaceutical Medicine|December 1, 2025
Considerations for Biosimilar Adoption in Pediatrics: A Scoping ReviewElaine Lau, Alicia Koo, Han Byul Kang, et al.
Pharmaceutical Medicine|December 9, 2023
"Regulatory Sandboxes" Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal ProductsMathieu Guerriaud
Pageof 31